Similar articles for PMID: 20651262

Year	Number of Results
1998	1
2000	1
2001	1
2003	1
2005	5
2006	2
2007	8
2008	5
2009	7
2010	12
2011	18
2012	25
2013	28
2014	20
2015	21
2016	15
2017	19
2018	29
2019	26
2020	21
2021	25
2022	18
2023	4
2024	0

1

Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS).

Nakagawara J, Minematsu K, Okada Y, Tanahashi N, Nagahiro S, Mori E, Shinohara Y, Yamaguchi T; J-MARS Investigators. Nakagawara J, et al. Stroke. 2010 Sep;41(9):1984-9. doi: 10.1161/STROKEAHA.110.589606. Epub 2010 Jul 22. Stroke. 2010. PMID: 20651262 Clinical Trial.

2

Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.

Aoki S, Hosomi N, Sueda Y, Kono T, Takamatsu K, Ohyama H, Torii T, Kitamura T, Nomura E, Noda K, Ohtsuki T, Matsumoto M; HARP Registry Study Group. Aoki S, et al. J Stroke Cerebrovasc Dis. 2015 Dec;24(12):2747-53. doi: 10.1016/j.jstrokecerebrovasdis.2015.08.005. Epub 2015 Sep 7. J Stroke Cerebrovasc Dis. 2015. PMID: 26360972

3

Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).

Mori E, Minematsu K, Nakagawara J, Yamaguchi T; Japan Alteplase Clinical Trial (J-ACT) Group. Mori E, et al. J Stroke Cerebrovasc Dis. 2011 Nov;20(6):517-22. doi: 10.1016/j.jstrokecerebrovasdis.2010.04.001. Epub 2010 Aug 17. J Stroke Cerebrovasc Dis. 2011. PMID: 20719535 Clinical Trial.

4

Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.

Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, Abe K. Kono S, et al. J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1175-83. doi: 10.1016/j.jstrokecerebrovasdis.2013.02.010. Epub 2013 Mar 16. J Stroke Cerebrovasc Dis. 2013. PMID: 23507462

5

Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.

Dorado L, Ahmed N, Thomalla G, Lozano M, Malojcic B, Wani M, Millán M, Tomek A, Dávalos A. Dorado L, et al. Stroke. 2017 Mar;48(3):720-725. doi: 10.1161/STROKEAHA.116.014889. Epub 2017 Feb 7. Stroke. 2017. PMID: 28174326

6

Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT).

Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y; Japan Alteplase Clinical Trial (J-ACT) Group. Yamaguchi T, et al. Stroke. 2006 Jul;37(7):1810-5. doi: 10.1161/01.STR.0000227191.01792.e3. Epub 2006 Jun 8. Stroke. 2006. PMID: 16763187 Clinical Trial.

7

Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.

Ahmed N, Kellert L, Lees KR, Mikulik R, Tatlisumak T, Toni D; SITS Investigators. Ahmed N, et al. JAMA Neurol. 2013 Jul;70(7):837-44. doi: 10.1001/jamaneurol.2013.406. JAMA Neurol. 2013. PMID: 23689267

8

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K. Kono S, et al. J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2. J Stroke Cerebrovasc Dis. 2013. PMID: 21968092

9

Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.

Carr SJ, Wang X, Olavarria VV, Lavados PM, Rodriguez JA, Kim JS, Lee TH, Lindley RI, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Woodward M, Chalmers J, Anderson CS, Robinson TG; ENCHANTED Investigators. Carr SJ, et al. Stroke. 2017 Sep;48(9):2605-2609. doi: 10.1161/STROKEAHA.117.017808. Epub 2017 Jul 24. Stroke. 2017. PMID: 28739832

10

Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.

Miyagi T, Koga M, Shiokawa Y, Nakagawara J, Hasegawa Y, Furui E, Kimura K, Kario K, Okuda S, Yamagami H, Okada Y, Nezu T, Maeda K, Endo K, Minematsu K, Toyoda K. Miyagi T, et al. J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1098-106. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.013. Epub 2012 Oct 10. J Stroke Cerebrovasc Dis. 2013. PMID: 23063059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

265 results

Results by year